Economic Observation Network On April 13th, Tianhong Innovative Medicine ETF had a net subscription of -8 million shares, accounting for 0.37% of the ETF fund shares. The latest shares of the fund are 2.162 billion, with a cumulative increase of 1.796 billion over the past three years. The latest scale is 1.675 billion yuan, with a cumulative increase of 1.419 billion yuan over the past three years.
The fund has risen 39.71% in the past year, with a maximum drawdown of 23.99%. The current ETF yield is -0.14%, exceeding the historical 27%, indicating a low-risk zone with a small deviation from net asset value and a high margin of safety.
The above content is based on publicly available information and does not constitute investment advice.

Xu Ran, Vice Chairman of SEC and CEO of JD Group: 25 years old and in full bloom, with a promising future ahead

Technology Showcase | Honor Debuts YOYO Claw Lobster Technology, Creating a New Category of "Lobster Ben", Saving 50% on Word Element Consumption, and ushering in the Era of Everyone Raising Shrimp!

The "ChiNext Series ETF China Tour" gathers in Chengdu to discuss new opportunities for index investment